dienogest: Clinical Trials

14 trials of dienogest, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 3 unknown, 1 recruiting, 1 suspended. 14 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 314Completed 9, Unknown 3, Recruiting 1, Suspended 1
Phase 23Completed 1, Suspended 1, Unknown 1

Follow dienogest: new trials by email Literature Review of dienogest trials Research Report on dienogest

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
Indole-3-carbinol, Dienogest - Endometriosis
Phase 3RecruitingAlcea2902025-09-112025-09-18
Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery
Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate) - Endometriosis Ovary
Phase 3CompletedUniversitas Diponegoro802023-09-042024-12-11
Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma
Dienogest 2 MG, N-acetyl cysteine - Uterine Leiomyoma
Phase 2 / Phase 3CompletedAin Shams University402023-09-012024-12-16
Comparisons of the Therapeutic Effects of Dienogest and Danazol on Endometriosis
Dienogest, Danazol - Endometriosis
Phase 3UnknownFar Eastern Memorial Hospital1202023-02-252023-03-29
A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles
LPRI424 (dienogest/ethinylestradiol) - Contraception
Phase 3CompletedInsud Pharma10342019-12-032023-11-14
Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis
Dienogest 2 MG Oral Tablet, Yasmin - Endometriosis
Phase 2 / Phase 3UnknownAmerican University of Beirut Medical Center1002017-02-072021-04-15
Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas
Dienogest, Levonorgestrel - Endometriosis
Phase 2 / Phase 3SuspendedFundación Santa Fe de Bogota502015-11-012016-11-22
Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome
Dienogest, Fluoxetine, Placebo - Premenstrual Syndrome
Phase 3UnknownCairo University2102015-04-012020-12-01
Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients
Dienogest (Visanne, BAY86-5258), Placebo - Endometriosis
Phase 3CompletedBayer2502013-03-012015-11-25
Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis
EE20/DRSP(BAY86-5300), Placebo, Dienogest - Endometriosis
Phase 3CompletedBayer3122012-10-012016-02-18
Effect on Primary Dysmenorrhea
Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027), Ethinyl estradiol, Levonorgestrel (Miranova), Placebo Match to SH T00658ID - Primary Dysmenorrhea
Phase 3CompletedBayer5072009-04-012015-08-24
To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)
Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027), Ortho Tri Cyclen Lo - Contraception
Phase 3CompletedBayer4092008-09-082024-11-20
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027), Placebo - Metrorrhagia
Phase 3CompletedBayer2312006-02-012014-12-30
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027), Placebo - Metrorrhagia
Phase 3CompletedBayer1902005-12-012013-11-27

Conditions studied

Endometriosis (6)  ·  Metrorrhagia (2)  ·  Myofibroma (1)  ·  Pelvic Pain (1)  ·  Premenstrual Syndrome (1)

Sponsors

Bayer (6)  ·  Ain Shams University (1)  ·  Alcea (1)  ·  American University of Beirut Medical Center (1)  ·  Cairo University (1)  ·  Far Eastern Memorial Hospital (1)  ·  Fundación Santa Fe de Bogota (1)  ·  Insud Pharma (1)  ·  Universitas Diponegoro (1)

Countries

United States (4)  ·  Canada (3)  ·  Egypt (2)  ·  Germany (2)  ·  Australia (1)  ·  Chile (1)  ·  China (1)  ·  Colombia (1)  ·  Czechia (1)  ·  Finland (1)  ·  Hungary (1)  ·  Indonesia (1)  ·  Italy (1)  ·  Japan (1)  ·  Lebanon (1)

Top investigators

Amr Mahmoud, lecturer (1)  ·  Antoine Abu Musa, MD (1)  ·  Enrico Colli, MD (1)  ·  Yuli Trisetiyono, SpOG (K) (1)

Results publications

PMID 21774563, PMID 22240178, PMID 18653184, PMID 21422847, PMID 21784734, PMID 22927764, PMID 23439617, PMID 23638631, PMID 24713413, PMID 28911925, PMID 30461337, PMID 34826668, PMID 37523477

NIH funding

2005 (1), 2008 (1)